The levels of inflammatory biomarkers in hemodialysis and peritoneal dialysis patients
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The levels of inflammatory biomarkers in hemodialysis and peritoneal dialysis patients
Authors
Keywords
-
Journal
Revista da Associacao Medica Brasileira
Volume 67, Issue 5, Pages 718-723
Publisher
FapUNIFESP (SciELO)
Online
2021-09-17
DOI
10.1590/1806-9282.20210056
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- FGF-23 serum levels and bone histomorphometric results in adult patients with chronic kidney disease on dialysis
- (2014) Florence Lima et al. CLINICAL NEPHROLOGY
- Serum sclerostin is an independent predictor of mortality in hemodialysis patients
- (2014) Flávia Letícia Carvalho Gonçalves et al. BMC Nephrology
- The Associations of Fibroblast Growth Factor 23 and Uncarboxylated Matrix Gla Protein With Mortality in Coronary Artery Disease: The Heart and Soul Study
- (2013) Benjamin D. Parker ANNALS OF INTERNAL MEDICINE
- The Relation between Renal Function and Serum Sclerostin in Adult Patients with CKD
- (2013) S. Pelletier et al. Clinical Journal of the American Society of Nephrology
- Can we use circulating biomarkers to monitor bone turnover in CKD haemodialysis patients? Hypotheses and facts
- (2013) P. Delanaye et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Serum levels of soluble secreted α-Klotho are decreased in the early stages of chronic kidney disease, making it a probable novel biomarker for early diagnosis
- (2012) Yoshiko Shimamura et al. Clinical and Experimental Nephrology
- Circulating Klotho levels: clinical relevance and relationship with tissue Klotho expression
- (2012) Tilman B. Drüeke et al. KIDNEY INTERNATIONAL
- Plasma Klotho is not related to kidney function and does not predict adverse outcome in patients with chronic kidney disease
- (2012) Sarah Seiler et al. KIDNEY INTERNATIONAL
- The emerging role of Klotho in clinical nephrology
- (2012) Ming Chang Hu et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
- (2011) Tamara Isakova et al. KIDNEY INTERNATIONAL
- Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients
- (2011) D. Cejka et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Sclerostin and Dickkopf-1 in Renal Osteodystrophy
- (2010) D. Cejka et al. Clinical Journal of the American Society of Nephrology
- p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease
- (2010) I.-W. Wu et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Circulating Fibroblast Growth Factor 23 in Patients with End-Stage Renal Disease Treated by Peritoneal Dialysis Is Intact and Biologically Active
- (2009) Takashi Shimada et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The relationship between adipokines, osteocalcin and bone quality in chronic kidney disease
- (2009) Justine Bacchetta et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction
- (2008) Shinsuke Yamada et al. CLINICAL ENDOCRINOLOGY
- Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
- (2008) Orlando M. Gutiérrez et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started